Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. 1994

K Onodera, and A Yamatodani, and T Watanabe, and H Wada
Department of Pharmacology, Tohoku University School of Dentistry, Sendai, Japan.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001519 Behavior The observable response of a man or animal to a situation. Acceptance Process,Acceptance Processes,Behaviors,Process, Acceptance,Processes, Acceptance
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders

Related Publications

K Onodera, and A Yamatodani, and T Watanabe, and H Wada
January 2003, Morfologiia (Saint Petersburg, Russia),
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
January 1988, Advances in experimental medicine and biology,
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
October 1996, Annals of the New York Academy of Sciences,
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
January 1991, Brain research bulletin,
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
February 1992, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
August 1997, Journal of neurochemistry,
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
August 1997, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
September 1991, Trends in neurosciences,
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
November 2001, Brain & development,
K Onodera, and A Yamatodani, and T Watanabe, and H Wada
September 2021, Biomolecules,
Copied contents to your clipboard!